News: adenocarcinoma

Targeting Lung Cancer in Never-smokers

Friday, November 12th, 2010

Lung cancer is the leading cause of cancer-related deaths worldwide, and between 10 percent and 15 percent of new cases arise in never-smokers. Never-smokers – as well as individuals of East-Asian ethnicity and those with adenocarcinoma tumors – appear more likely to respond to certain targeted therapies. William Pao, M.D., Ph.D., and colleagues at Fudan […]

VICC Launches Genome-Driven Therapy

Wednesday, August 4th, 2010

Vanderbilt-Ingram Cancer Center (VICC) has launched its new Personalized Cancer Medicine Initiative, becoming the first cancer center in the Southeast and one of the first in the nation to offer adult cancer patients routine “genotyping” of their tumors at the DNA level. This information will then be used to personalize treatment by matching the appropriate […]